Zyla Life Sciences (fka ZCOR)

[realfast95]

Funny (for some) part of the earnings call
http://seekingalpha.com/article/4053766-egalets-eglt-ceo-bob-radie-q4-2016-results-earnings-call-transcript?page=9


The next question comes from Christina Hung of Goldman Sachs [Correction by company - Stated employer as Goldman Sachs, employment has not been verified]. Please go ahead.

Christina Hung

Yes, hi, Bob, thank you for taking my call. So 2016 was a challenging and pivotal year, however Egalet did less than $20 million of sales in a market worth over $12.5 billion that's negligible. You lost nearly $100 million. The ARYMO FDA approval announcement was a disaster and your shares are trading at an all time low. But you have dozens of transaction lawsuits against you. Don't you think it's time for management change including yourself?

Bob Radie

Christina, I appreciate the question obviously when you paint things that way it sounds all gloom and doom but I think we look at things quite differently here in terms of our revenue projections. We have actually grown consistently quarter-over-quarter. We are continuing to move our established products forward which we're very, very excited about. We believe that the introduction of ARYMO and the approval of ARYMO is a significant advancement for the company it validates the Guardian Technology and everything that we believed in. I can always understand how markets react to certain things, I think having a product approved is a big step forward for the company, it validates the technology. We believe that ARYMO wouldn't has not lost one day of its long-term revenue potential for this product. So we will continue to run the business the way we believe is the right way to run the business and we appreciate your question.

Christina Hung

Is there anything you can say to give us confidence in your credibility moving forward?

Bob Radie

This is a very experienced management team. We have all been part of a lot of different companies before and so we are going to continue to execute on our strategy and do everything that we can to be successful. Thank you.